nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—ABCB1—peripheral nervous system neoplasm	0.302	1	CbGaD
Sertraline—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0576	0.137	CbGbCtD
Sertraline—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0363	0.0865	CbGbCtD
Sertraline—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0318	0.0757	CbGbCtD
Sertraline—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0318	0.0757	CbGbCtD
Sertraline—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0304	0.0725	CbGbCtD
Sertraline—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0291	0.0692	CbGbCtD
Sertraline—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0247	0.0587	CbGbCtD
Sertraline—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.022	0.0524	CbGbCtD
Sertraline—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.019	0.0453	CbGbCtD
Sertraline—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0177	0.0421	CbGbCtD
Sertraline—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0165	0.0394	CbGbCtD
Sertraline—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0142	0.0338	CbGbCtD
Sertraline—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0136	0.0323	CbGbCtD
Sertraline—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.013	0.031	CbGbCtD
Sertraline—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0127	0.0301	CbGbCtD
Sertraline—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0124	0.0296	CbGbCtD
Sertraline—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00848	0.0202	CbGbCtD
Sertraline—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00813	0.0193	CbGbCtD
Sertraline—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00799	0.019	CbGbCtD
Sertraline—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00745	0.0177	CbGbCtD
Sertraline—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00508	0.0121	CbGbCtD
Sertraline—SLC6A3—nerve—peripheral nervous system neoplasm	0.000788	0.0758	CbGeAlD
Sertraline—SLC6A3—ganglion—peripheral nervous system neoplasm	0.000778	0.0748	CbGeAlD
Sertraline—SLC6A4—ganglion—peripheral nervous system neoplasm	0.000713	0.0686	CbGeAlD
Sertraline—MAOB—nerve—peripheral nervous system neoplasm	0.000687	0.066	CbGeAlD
Sertraline—MAOB—ganglion—peripheral nervous system neoplasm	0.000678	0.0652	CbGeAlD
Sertraline—SLC6A2—nerve—peripheral nervous system neoplasm	0.000636	0.0611	CbGeAlD
Sertraline—SLC6A2—ganglion—peripheral nervous system neoplasm	0.000628	0.0604	CbGeAlD
Sertraline—MAOA—nerve—peripheral nervous system neoplasm	0.000586	0.0563	CbGeAlD
Sertraline—MAOA—ganglion—peripheral nervous system neoplasm	0.000579	0.0556	CbGeAlD
Sertraline—SLC6A3—Parkinsons Disease Pathway—PINK1—peripheral nervous system neoplasm	0.000508	0.0811	CbGpPWpGaD
Sertraline—MAOB—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.000411	0.0656	CbGpPWpGaD
Sertraline—MAOA—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000404	0.0646	CbGpPWpGaD
Sertraline—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.000376	0.06	CbGpPWpGaD
Sertraline—SIGMAR1—trigeminal ganglion—peripheral nervous system neoplasm	0.000348	0.0335	CbGeAlD
Sertraline—SLC6A4—Synaptic Vesicle Pathway—SYP—peripheral nervous system neoplasm	0.00034	0.0542	CbGpPWpGaD
Sertraline—SLC6A3—brainstem—peripheral nervous system neoplasm	0.000338	0.0325	CbGeAlD
Sertraline—MAOB—trigeminal ganglion—peripheral nervous system neoplasm	0.000333	0.032	CbGeAlD
Sertraline—SIGMAR1—parotid gland—peripheral nervous system neoplasm	0.000328	0.0315	CbGeAlD
Sertraline—MAOB—parotid gland—peripheral nervous system neoplasm	0.000314	0.0302	CbGeAlD
Sertraline—SLC6A4—brainstem—peripheral nervous system neoplasm	0.00031	0.0298	CbGeAlD
Sertraline—MAOB—brainstem—peripheral nervous system neoplasm	0.000295	0.0283	CbGeAlD
Sertraline—MAOA—trigeminal ganglion—peripheral nervous system neoplasm	0.000284	0.0273	CbGeAlD
Sertraline—SLC6A2—brainstem—peripheral nervous system neoplasm	0.000273	0.0262	CbGeAlD
Sertraline—MAOA—parotid gland—peripheral nervous system neoplasm	0.000268	0.0258	CbGeAlD
Sertraline—MAOA—Dopamine metabolism—TH—peripheral nervous system neoplasm	0.000258	0.0412	CbGpPWpGaD
Sertraline—MAOA—brainstem—peripheral nervous system neoplasm	0.000252	0.0242	CbGeAlD
Sertraline—MAOA—Biogenic Amine Synthesis—TH—peripheral nervous system neoplasm	0.00023	0.0367	CbGpPWpGaD
Sertraline—MAOB—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.000205	0.0327	CbGpPWpGaD
Sertraline—SLC6A3—cerebellum—peripheral nervous system neoplasm	0.000167	0.016	CbGeAlD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000163	0.0261	CbGpPWpGaD
Sertraline—SLC6A4—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000153	0.0244	CbGpPWpGaD
Sertraline—SIGMAR1—cerebellum—peripheral nervous system neoplasm	0.000152	0.0146	CbGeAlD
Sertraline—CYP2D6—brainstem—peripheral nervous system neoplasm	0.000149	0.0144	CbGeAlD
Sertraline—MAOB—cerebellum—peripheral nervous system neoplasm	0.000145	0.014	CbGeAlD
Sertraline—Maprotiline—ABCB1—peripheral nervous system neoplasm	0.000138	1	CrCbGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.000134	0.0214	CbGpPWpGaD
Sertraline—CYP2D6—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	0.000133	0.0212	CbGpPWpGaD
Sertraline—SLC6A2—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000132	0.021	CbGpPWpGaD
Sertraline—MAOA—cerebellum—peripheral nervous system neoplasm	0.000124	0.0119	CbGeAlD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—TH—peripheral nervous system neoplasm	0.000123	0.0196	CbGpPWpGaD
Sertraline—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	0.000122	0.0117	CbGeAlD
Sertraline—SLC6A3—Alpha-synuclein signaling—TH—peripheral nervous system neoplasm	0.00012	0.0191	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—TH—peripheral nervous system neoplasm	0.000117	0.0186	CbGpPWpGaD
Sertraline—SLC6A3—Parkinsons Disease Pathway—TH—peripheral nervous system neoplasm	0.000102	0.0162	CbGpPWpGaD
Sertraline—CYP3A4—Codeine and Morphine Metabolism—ABCB1—peripheral nervous system neoplasm	8.67e-05	0.0138	CbGpPWpGaD
Sertraline—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000288	CcSEcCtD
Sertraline—Rash—Dactinomycin—peripheral nervous system neoplasm	7.51e-05	0.000288	CcSEcCtD
Sertraline—Decreased appetite—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000287	CcSEcCtD
Sertraline—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000286	CcSEcCtD
Sertraline—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	7.44e-05	0.000285	CcSEcCtD
Sertraline—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	7.44e-05	0.000285	CcSEcCtD
Sertraline—Fatigue—Etoposide—peripheral nervous system neoplasm	7.43e-05	0.000285	CcSEcCtD
Sertraline—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000285	CcSEcCtD
Sertraline—Jaundice—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000283	CcSEcCtD
Sertraline—Stomatitis—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000283	CcSEcCtD
Sertraline—Pain—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000283	CcSEcCtD
Sertraline—Constipation—Etoposide—peripheral nervous system neoplasm	7.37e-05	0.000283	CcSEcCtD
Sertraline—CYP2D6—cerebellum—peripheral nervous system neoplasm	7.37e-05	0.00708	CbGeAlD
Sertraline—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000282	CcSEcCtD
Sertraline—CYP3A4—Irinotecan Pathway—BCHE—peripheral nervous system neoplasm	7.36e-05	0.0117	CbGpPWpGaD
Sertraline—Dysuria—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000282	CcSEcCtD
Sertraline—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.00028	CcSEcCtD
Sertraline—Dizziness—Alitretinoin—peripheral nervous system neoplasm	7.31e-05	0.00028	CcSEcCtD
Sertraline—Diarrhoea—Vincristine—peripheral nervous system neoplasm	7.28e-05	0.000279	CcSEcCtD
Sertraline—Sweating—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.000278	CcSEcCtD
Sertraline—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	7.27e-05	0.000278	CcSEcCtD
Sertraline—Haematuria—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000277	CcSEcCtD
Sertraline—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	7.18e-05	0.000275	CcSEcCtD
Sertraline—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	7.17e-05	0.000275	CcSEcCtD
Sertraline—Weight increased—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000274	CcSEcCtD
Sertraline—Epistaxis—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.000274	CcSEcCtD
Sertraline—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	7.12e-05	0.000273	CcSEcCtD
Sertraline—Sinusitis—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.000273	CcSEcCtD
Sertraline—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	7.11e-05	0.000272	CcSEcCtD
Sertraline—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000272	CcSEcCtD
Sertraline—Nausea—Dactinomycin—peripheral nervous system neoplasm	7.08e-05	0.000271	CcSEcCtD
Sertraline—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000271	CcSEcCtD
Sertraline—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	7.05e-05	0.00027	CcSEcCtD
Sertraline—Dizziness—Vincristine—peripheral nervous system neoplasm	7.04e-05	0.00027	CcSEcCtD
Sertraline—Vomiting—Alitretinoin—peripheral nervous system neoplasm	7.02e-05	0.000269	CcSEcCtD
Sertraline—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000269	CcSEcCtD
Sertraline—Rash—Alitretinoin—peripheral nervous system neoplasm	6.97e-05	0.000267	CcSEcCtD
Sertraline—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	6.96e-05	0.000267	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000266	CcSEcCtD
Sertraline—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	6.94e-05	0.000266	CcSEcCtD
Sertraline—Bradycardia—Epirubicin—peripheral nervous system neoplasm	6.93e-05	0.000265	CcSEcCtD
Sertraline—Headache—Alitretinoin—peripheral nervous system neoplasm	6.92e-05	0.000265	CcSEcCtD
Sertraline—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.000263	CcSEcCtD
Sertraline—Urticaria—Etoposide—peripheral nervous system neoplasm	6.85e-05	0.000263	CcSEcCtD
Sertraline—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000262	CcSEcCtD
Sertraline—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000262	CcSEcCtD
Sertraline—Jaundice—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000262	CcSEcCtD
Sertraline—Rhinitis—Epirubicin—peripheral nervous system neoplasm	6.82e-05	0.000261	CcSEcCtD
Sertraline—Body temperature increased—Etoposide—peripheral nervous system neoplasm	6.82e-05	0.000261	CcSEcCtD
Sertraline—Abdominal pain—Etoposide—peripheral nervous system neoplasm	6.82e-05	0.000261	CcSEcCtD
Sertraline—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000261	CcSEcCtD
Sertraline—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000261	CcSEcCtD
Sertraline—Hepatitis—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.000261	CcSEcCtD
Sertraline—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000259	CcSEcCtD
Sertraline—Vomiting—Vincristine—peripheral nervous system neoplasm	6.77e-05	0.000259	CcSEcCtD
Sertraline—Asthenia—Cisplatin—peripheral nervous system neoplasm	6.75e-05	0.000259	CcSEcCtD
Sertraline—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000259	CcSEcCtD
Sertraline—Sweating—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000258	CcSEcCtD
Sertraline—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000258	CcSEcCtD
Sertraline—Rash—Vincristine—peripheral nervous system neoplasm	6.71e-05	0.000257	CcSEcCtD
Sertraline—Dermatitis—Vincristine—peripheral nervous system neoplasm	6.71e-05	0.000257	CcSEcCtD
Sertraline—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000257	CcSEcCtD
Sertraline—Haematuria—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000256	CcSEcCtD
Sertraline—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000256	CcSEcCtD
Sertraline—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	6.67e-05	0.000256	CcSEcCtD
Sertraline—Headache—Vincristine—peripheral nervous system neoplasm	6.67e-05	0.000256	CcSEcCtD
Sertraline—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000254	CcSEcCtD
Sertraline—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	6.61e-05	0.000254	CcSEcCtD
Sertraline—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000252	CcSEcCtD
Sertraline—Nausea—Alitretinoin—peripheral nervous system neoplasm	6.56e-05	0.000251	CcSEcCtD
Sertraline—Visual impairment—Epirubicin—peripheral nervous system neoplasm	6.56e-05	0.000251	CcSEcCtD
Sertraline—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000251	CcSEcCtD
Sertraline—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	6.44e-05	0.000247	CcSEcCtD
Sertraline—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000247	CcSEcCtD
Sertraline—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	6.41e-05	0.000246	CcSEcCtD
Sertraline—Eye disorder—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000244	CcSEcCtD
Sertraline—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	6.35e-05	0.000244	CcSEcCtD
Sertraline—Tinnitus—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000243	CcSEcCtD
Sertraline—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000243	CcSEcCtD
Sertraline—Nausea—Vincristine—peripheral nervous system neoplasm	6.32e-05	0.000242	CcSEcCtD
Sertraline—Flushing—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000242	CcSEcCtD
Sertraline—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000242	CcSEcCtD
Sertraline—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	6.31e-05	0.000242	CcSEcCtD
Sertraline—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000241	CcSEcCtD
Sertraline—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	6.3e-05	0.000241	CcSEcCtD
Sertraline—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	6.29e-05	0.01	CbGpPWpGaD
Sertraline—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.00024	CcSEcCtD
Sertraline—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000239	CcSEcCtD
Sertraline—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	6.22e-05	0.000238	CcSEcCtD
Sertraline—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000238	CcSEcCtD
Sertraline—Asthenia—Etoposide—peripheral nervous system neoplasm	6.19e-05	0.000237	CcSEcCtD
Sertraline—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000237	CcSEcCtD
Sertraline—Angiopathy—Epirubicin—peripheral nervous system neoplasm	6.17e-05	0.000237	CcSEcCtD
Sertraline—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	6.17e-05	0.000237	CcSEcCtD
Sertraline—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	6.15e-05	0.000236	CcSEcCtD
Sertraline—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	6.13e-05	0.000235	CcSEcCtD
Sertraline—Chills—Epirubicin—peripheral nervous system neoplasm	6.1e-05	0.000234	CcSEcCtD
Sertraline—Pruritus—Etoposide—peripheral nervous system neoplasm	6.1e-05	0.000234	CcSEcCtD
Sertraline—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	6.08e-05	0.000233	CcSEcCtD
Sertraline—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	6.07e-05	0.000233	CcSEcCtD
Sertraline—Alopecia—Epirubicin—peripheral nervous system neoplasm	6.01e-05	0.00023	CcSEcCtD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	6e-05	0.00957	CbGpPWpGaD
Sertraline—Vomiting—Cisplatin—peripheral nervous system neoplasm	5.98e-05	0.000229	CcSEcCtD
Sertraline—Mental disorder—Epirubicin—peripheral nervous system neoplasm	5.96e-05	0.000228	CcSEcCtD
Sertraline—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000228	CcSEcCtD
Sertraline—Rash—Cisplatin—peripheral nervous system neoplasm	5.94e-05	0.000227	CcSEcCtD
Sertraline—Dermatitis—Cisplatin—peripheral nervous system neoplasm	5.93e-05	0.000227	CcSEcCtD
Sertraline—Erythema—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000227	CcSEcCtD
Sertraline—Malnutrition—Epirubicin—peripheral nervous system neoplasm	5.92e-05	0.000227	CcSEcCtD
Sertraline—Diarrhoea—Etoposide—peripheral nervous system neoplasm	5.9e-05	0.000226	CcSEcCtD
Sertraline—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	5.88e-05	0.000225	CcSEcCtD
Sertraline—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000225	CcSEcCtD
Sertraline—Flushing—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000224	CcSEcCtD
Sertraline—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000224	CcSEcCtD
Sertraline—Flatulence—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000224	CcSEcCtD
Sertraline—Tension—Epirubicin—peripheral nervous system neoplasm	5.81e-05	0.000223	CcSEcCtD
Sertraline—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	5.8e-05	0.000222	CcSEcCtD
Sertraline—Nervousness—Epirubicin—peripheral nervous system neoplasm	5.75e-05	0.00022	CcSEcCtD
Sertraline—Back pain—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.00022	CcSEcCtD
Sertraline—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	5.71e-05	0.000219	CcSEcCtD
Sertraline—Dizziness—Etoposide—peripheral nervous system neoplasm	5.7e-05	0.000219	CcSEcCtD
Sertraline—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000218	CcSEcCtD
Sertraline—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	5.69e-05	0.000218	CcSEcCtD
Sertraline—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.67e-05	0.000217	CcSEcCtD
Sertraline—Chills—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.000216	CcSEcCtD
Sertraline—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	5.62e-05	0.000216	CcSEcCtD
Sertraline—Nausea—Cisplatin—peripheral nervous system neoplasm	5.59e-05	0.000214	CcSEcCtD
Sertraline—Alopecia—Doxorubicin—peripheral nervous system neoplasm	5.56e-05	0.000213	CcSEcCtD
Sertraline—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000211	CcSEcCtD
Sertraline—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	5.5e-05	0.000211	CcSEcCtD
Sertraline—Vomiting—Etoposide—peripheral nervous system neoplasm	5.48e-05	0.00021	CcSEcCtD
Sertraline—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.00021	CcSEcCtD
Sertraline—Erythema—Doxorubicin—peripheral nervous system neoplasm	5.48e-05	0.00021	CcSEcCtD
Sertraline—Anaemia—Epirubicin—peripheral nervous system neoplasm	5.47e-05	0.00021	CcSEcCtD
Sertraline—Agitation—Epirubicin—peripheral nervous system neoplasm	5.44e-05	0.000209	CcSEcCtD
Sertraline—Rash—Etoposide—peripheral nervous system neoplasm	5.44e-05	0.000208	CcSEcCtD
Sertraline—Dermatitis—Etoposide—peripheral nervous system neoplasm	5.43e-05	0.000208	CcSEcCtD
Sertraline—Headache—Etoposide—peripheral nervous system neoplasm	5.4e-05	0.000207	CcSEcCtD
Sertraline—Flatulence—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000207	CcSEcCtD
Sertraline—Tension—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000206	CcSEcCtD
Sertraline—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	5.37e-05	0.000206	CcSEcCtD
Sertraline—Malaise—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000205	CcSEcCtD
Sertraline—Nervousness—Doxorubicin—peripheral nervous system neoplasm	5.32e-05	0.000204	CcSEcCtD
Sertraline—Vertigo—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000204	CcSEcCtD
Sertraline—Syncope—Epirubicin—peripheral nervous system neoplasm	5.31e-05	0.000204	CcSEcCtD
Sertraline—Leukopenia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000203	CcSEcCtD
Sertraline—ABCB1—cerebellum—peripheral nervous system neoplasm	5.3e-05	0.0051	CbGeAlD
Sertraline—Back pain—Doxorubicin—peripheral nervous system neoplasm	5.3e-05	0.000203	CcSEcCtD
Sertraline—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	5.27e-05	0.000202	CcSEcCtD
Sertraline—Palpitations—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000201	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—NF1—peripheral nervous system neoplasm	5.22e-05	0.00834	CbGpPWpGaD
Sertraline—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.0002	CcSEcCtD
Sertraline—Cough—Epirubicin—peripheral nervous system neoplasm	5.17e-05	0.000198	CcSEcCtD
Sertraline—Convulsion—Epirubicin—peripheral nervous system neoplasm	5.13e-05	0.000197	CcSEcCtD
Sertraline—Nausea—Etoposide—peripheral nervous system neoplasm	5.12e-05	0.000196	CcSEcCtD
Sertraline—Hypertension—Epirubicin—peripheral nervous system neoplasm	5.11e-05	0.000196	CcSEcCtD
Sertraline—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	5.08e-05	0.000195	CcSEcCtD
Sertraline—Anaemia—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.000194	CcSEcCtD
Sertraline—Chest pain—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000193	CcSEcCtD
Sertraline—Arthralgia—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000193	CcSEcCtD
Sertraline—Myalgia—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000193	CcSEcCtD
Sertraline—Agitation—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.000193	CcSEcCtD
Sertraline—Anxiety—Epirubicin—peripheral nervous system neoplasm	5.03e-05	0.000193	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000192	CcSEcCtD
Sertraline—Discomfort—Epirubicin—peripheral nervous system neoplasm	4.98e-05	0.000191	CcSEcCtD
Sertraline—Malaise—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000189	CcSEcCtD
Sertraline—Dry mouth—Epirubicin—peripheral nervous system neoplasm	4.93e-05	0.000189	CcSEcCtD
Sertraline—Vertigo—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000189	CcSEcCtD
Sertraline—Syncope—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000188	CcSEcCtD
Sertraline—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	4.91e-05	0.000188	CcSEcCtD
Sertraline—Confusional state—Epirubicin—peripheral nervous system neoplasm	4.87e-05	0.000187	CcSEcCtD
Sertraline—Palpitations—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000186	CcSEcCtD
Sertraline—Oedema—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000185	CcSEcCtD
Sertraline—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000185	CcSEcCtD
Sertraline—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000185	CcSEcCtD
Sertraline—Cough—Doxorubicin—peripheral nervous system neoplasm	4.78e-05	0.000183	CcSEcCtD
Sertraline—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.76e-05	0.00759	CbGpPWpGaD
Sertraline—Shock—Epirubicin—peripheral nervous system neoplasm	4.76e-05	0.000182	CcSEcCtD
Sertraline—Convulsion—Doxorubicin—peripheral nervous system neoplasm	4.75e-05	0.000182	CcSEcCtD
Sertraline—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—peripheral nervous system neoplasm	4.74e-05	0.00757	CbGpPWpGaD
Sertraline—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000182	CcSEcCtD
Sertraline—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000181	CcSEcCtD
Sertraline—Hypertension—Doxorubicin—peripheral nervous system neoplasm	4.73e-05	0.000181	CcSEcCtD
Sertraline—Tachycardia—Epirubicin—peripheral nervous system neoplasm	4.72e-05	0.000181	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	4.7e-05	0.00751	CbGpPWpGaD
Sertraline—Skin disorder—Epirubicin—peripheral nervous system neoplasm	4.7e-05	0.00018	CcSEcCtD
Sertraline—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	4.67e-05	0.000179	CcSEcCtD
Sertraline—Myalgia—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000179	CcSEcCtD
Sertraline—Chest pain—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000179	CcSEcCtD
Sertraline—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000179	CcSEcCtD
Sertraline—Anxiety—Doxorubicin—peripheral nervous system neoplasm	4.65e-05	0.000178	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000178	CcSEcCtD
Sertraline—SLC6A4—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	4.61e-05	0.00736	CbGpPWpGaD
Sertraline—Discomfort—Doxorubicin—peripheral nervous system neoplasm	4.61e-05	0.000177	CcSEcCtD
Sertraline—Anorexia—Epirubicin—peripheral nervous system neoplasm	4.61e-05	0.000177	CcSEcCtD
Sertraline—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	4.56e-05	0.000175	CcSEcCtD
Sertraline—Hypotension—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.000173	CcSEcCtD
Sertraline—Confusional state—Doxorubicin—peripheral nervous system neoplasm	4.51e-05	0.000173	CcSEcCtD
Sertraline—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000171	CcSEcCtD
Sertraline—Oedema—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000171	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	4.4e-05	0.000169	CcSEcCtD
Sertraline—Shock—Doxorubicin—peripheral nervous system neoplasm	4.4e-05	0.000169	CcSEcCtD
Sertraline—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000168	CcSEcCtD
Sertraline—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000168	CcSEcCtD
Sertraline—Insomnia—Epirubicin—peripheral nervous system neoplasm	4.37e-05	0.000168	CcSEcCtD
Sertraline—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	4.37e-05	0.000167	CcSEcCtD
Sertraline—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	4.34e-05	0.000167	CcSEcCtD
Sertraline—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000166	CcSEcCtD
Sertraline—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	4.34e-05	0.00692	CbGpPWpGaD
Sertraline—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000166	CcSEcCtD
Sertraline—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	4.31e-05	0.000165	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	4.31e-05	0.00688	CbGpPWpGaD
Sertraline—Somnolence—Epirubicin—peripheral nervous system neoplasm	4.3e-05	0.000165	CcSEcCtD
Sertraline—Anorexia—Doxorubicin—peripheral nervous system neoplasm	4.26e-05	0.000163	CcSEcCtD
Sertraline—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000163	CcSEcCtD
Sertraline—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000161	CcSEcCtD
Sertraline—Hypotension—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.00016	CcSEcCtD
Sertraline—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00016	CcSEcCtD
Sertraline—Fatigue—Epirubicin—peripheral nervous system neoplasm	4.17e-05	0.00016	CcSEcCtD
Sertraline—SLC6A3—Parkinsons Disease Pathway—CASP3—peripheral nervous system neoplasm	4.13e-05	0.0066	CbGpPWpGaD
Sertraline—Pain—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000158	CcSEcCtD
Sertraline—Constipation—Epirubicin—peripheral nervous system neoplasm	4.13e-05	0.000158	CcSEcCtD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	4.13e-05	0.00659	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.07e-05	0.000156	CcSEcCtD
Sertraline—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.05e-05	0.000155	CcSEcCtD
Sertraline—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000154	CcSEcCtD
Sertraline—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000153	CcSEcCtD
Sertraline—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000153	CcSEcCtD
Sertraline—Somnolence—Doxorubicin—peripheral nervous system neoplasm	3.98e-05	0.000152	CcSEcCtD
Sertraline—SLC6A2—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	3.96e-05	0.00633	CbGpPWpGaD
Sertraline—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	3.95e-05	0.000151	CcSEcCtD
Sertraline—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000151	CcSEcCtD
Sertraline—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000149	CcSEcCtD
Sertraline—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000148	CcSEcCtD
Sertraline—Fatigue—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	0.000148	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	3.85e-05	0.00615	CbGpPWpGaD
Sertraline—Urticaria—Epirubicin—peripheral nervous system neoplasm	3.84e-05	0.000147	CcSEcCtD
Sertraline—Pain—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000147	CcSEcCtD
Sertraline—Constipation—Doxorubicin—peripheral nervous system neoplasm	3.82e-05	0.000147	CcSEcCtD
Sertraline—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000146	CcSEcCtD
Sertraline—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000146	CcSEcCtD
Sertraline—MAOB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.79e-05	0.00605	CbGpPWpGaD
Sertraline—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	3.69e-05	0.000141	CcSEcCtD
Sertraline—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	3.66e-05	0.00014	CcSEcCtD
Sertraline—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	3.56e-05	0.000136	CcSEcCtD
Sertraline—Urticaria—Doxorubicin—peripheral nervous system neoplasm	3.55e-05	0.000136	CcSEcCtD
Sertraline—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000136	CcSEcCtD
Sertraline—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	3.54e-05	0.000136	CcSEcCtD
Sertraline—SLC6A4—NRF2 pathway—HGF—peripheral nervous system neoplasm	3.53e-05	0.00564	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	3.53e-05	0.00564	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	3.53e-05	0.00564	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TH—peripheral nervous system neoplasm	3.52e-05	0.00562	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	3.51e-05	0.00561	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	3.51e-05	0.0056	CbGpPWpGaD
Sertraline—Asthenia—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000133	CcSEcCtD
Sertraline—Pruritus—Epirubicin—peripheral nervous system neoplasm	3.42e-05	0.000131	CcSEcCtD
Sertraline—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000127	CcSEcCtD
Sertraline—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.3e-05	0.000126	CcSEcCtD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—peripheral nervous system neoplasm	3.29e-05	0.00526	CbGpPWpGaD
Sertraline—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000123	CcSEcCtD
Sertraline—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.2e-05	0.000123	CcSEcCtD
Sertraline—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.16e-05	0.000121	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	3.13e-05	0.005	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	3.08e-05	0.00492	CbGpPWpGaD
Sertraline—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.07e-05	0.000118	CcSEcCtD
Sertraline—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.06e-05	0.000117	CcSEcCtD
Sertraline—Rash—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000117	CcSEcCtD
Sertraline—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.05e-05	0.000117	CcSEcCtD
Sertraline—SLC6A2—NRF2 pathway—HGF—peripheral nervous system neoplasm	3.04e-05	0.00485	CbGpPWpGaD
Sertraline—Headache—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000116	CcSEcCtD
Sertraline—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.96e-05	0.000113	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	2.88e-05	0.00459	CbGpPWpGaD
Sertraline—Nausea—Epirubicin—peripheral nervous system neoplasm	2.87e-05	0.00011	CcSEcCtD
Sertraline—SLC6A3—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	2.86e-05	0.00457	CbGpPWpGaD
Sertraline—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	2.86e-05	0.00457	CbGpPWpGaD
Sertraline—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.84e-05	0.000109	CcSEcCtD
Sertraline—Rash—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000108	CcSEcCtD
Sertraline—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.82e-05	0.000108	CcSEcCtD
Sertraline—Headache—Doxorubicin—peripheral nervous system neoplasm	2.8e-05	0.000107	CcSEcCtD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	2.76e-05	0.00441	CbGpPWpGaD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	2.72e-05	0.00435	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—HGF—peripheral nervous system neoplasm	2.69e-05	0.0043	CbGpPWpGaD
Sertraline—Nausea—Doxorubicin—peripheral nervous system neoplasm	2.66e-05	0.000102	CcSEcCtD
Sertraline—MAOB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.56e-05	0.00408	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.5e-05	0.00399	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.4e-05	0.00383	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.38e-05	0.00379	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—BCHE—peripheral nervous system neoplasm	2.36e-05	0.00377	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	2.21e-05	0.00353	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—BCHE—peripheral nervous system neoplasm	2.19e-05	0.0035	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.13e-05	0.00339	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GNS—peripheral nervous system neoplasm	1.85e-05	0.00295	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NME1—peripheral nervous system neoplasm	1.77e-05	0.00283	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.75e-05	0.0028	CbGpPWpGaD
Sertraline—MAOB—Metabolism—COX2—peripheral nervous system neoplasm	1.71e-05	0.00272	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.71e-05	0.00272	CbGpPWpGaD
Sertraline—MAOA—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.61e-05	0.00256	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.56e-05	0.00248	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.49e-05	0.00238	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	1.44e-05	0.00229	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	1.35e-05	0.00216	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	1.33e-05	0.00212	CbGpPWpGaD
Sertraline—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	1.31e-05	0.00209	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.27e-05	0.00203	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	1.23e-05	0.00197	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	1.18e-05	0.00188	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GNS—peripheral nervous system neoplasm	1.16e-05	0.00185	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	1.14e-05	0.00183	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	1.13e-05	0.0018	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.12e-05	0.0018	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.12e-05	0.0018	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ENO2—peripheral nervous system neoplasm	1.12e-05	0.00179	CbGpPWpGaD
Sertraline—MAOA—Metabolism—NME1—peripheral nervous system neoplasm	1.11e-05	0.00178	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	1.1e-05	0.00176	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.1e-05	0.00175	CbGpPWpGaD
Sertraline—MAOA—Metabolism—COX2—peripheral nervous system neoplasm	1.07e-05	0.00171	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	1.06e-05	0.00169	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.03e-05	0.00165	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.03e-05	0.00164	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.02e-05	0.00163	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.01e-05	0.00161	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1e-05	0.0016	CbGpPWpGaD
Sertraline—MAOB—Metabolism—BCHE—peripheral nervous system neoplasm	9.47e-06	0.00151	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	9.18e-06	0.00147	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.05e-06	0.00144	CbGpPWpGaD
Sertraline—MAOB—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.03e-06	0.00144	CbGpPWpGaD
Sertraline—MAOB—Metabolism—TH—peripheral nervous system neoplasm	8.9e-06	0.00142	CbGpPWpGaD
Sertraline—SLC6A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	8.88e-06	0.00142	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	8.77e-06	0.0014	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	8.64e-06	0.00138	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.6e-06	0.00121	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	7.42e-06	0.00118	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	7.27e-06	0.00116	CbGpPWpGaD
Sertraline—MAOB—Metabolism—GNAS—peripheral nervous system neoplasm	7.27e-06	0.00116	CbGpPWpGaD
Sertraline—MAOA—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.23e-06	0.00115	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	7.16e-06	0.00114	CbGpPWpGaD
Sertraline—MAOB—Metabolism—ABCB1—peripheral nervous system neoplasm	7.13e-06	0.00114	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ENO2—peripheral nervous system neoplasm	7.03e-06	0.00112	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.99e-06	0.00112	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	6.97e-06	0.00111	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.93e-06	0.00111	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.76e-06	0.00108	CbGpPWpGaD
Sertraline—SLC6A3—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	6.72e-06	0.00107	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	6.71e-06	0.00107	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	6.31e-06	0.00101	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	6.22e-06	0.000993	CbGpPWpGaD
Sertraline—MAOA—Metabolism—BCHE—peripheral nervous system neoplasm	5.94e-06	0.000948	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.92e-06	0.000945	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	5.76e-06	0.000919	CbGpPWpGaD
Sertraline—MAOA—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.67e-06	0.000905	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	5.65e-06	0.000902	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	5.59e-06	0.000892	CbGpPWpGaD
Sertraline—MAOA—Metabolism—TH—peripheral nervous system neoplasm	5.59e-06	0.000892	CbGpPWpGaD
Sertraline—MAOA—Neuronal System—HRAS—peripheral nervous system neoplasm	5.54e-06	0.000884	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	5.49e-06	0.000877	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	5.36e-06	0.000856	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	5.27e-06	0.000841	CbGpPWpGaD
Sertraline—SLC6A3—Neuronal System—HRAS—peripheral nervous system neoplasm	5.15e-06	0.000821	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	5.14e-06	0.000821	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	5.07e-06	0.000809	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	5.05e-06	0.000807	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	5.01e-06	0.0008	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	4.95e-06	0.00079	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.92e-06	0.000785	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	4.84e-06	0.000773	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	4.8e-06	0.000767	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	4.66e-06	0.000744	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	4.62e-06	0.000738	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.57e-06	0.000729	CbGpPWpGaD
Sertraline—MAOA—Metabolism—GNAS—peripheral nervous system neoplasm	4.56e-06	0.000728	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	4.5e-06	0.000718	CbGpPWpGaD
Sertraline—MAOA—Metabolism—ABCB1—peripheral nervous system neoplasm	4.47e-06	0.000714	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	4.41e-06	0.000704	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	4.4e-06	0.000703	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	4.28e-06	0.000683	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	4.1e-06	0.000655	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	3.95e-06	0.000631	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	3.72e-06	0.000594	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	3.62e-06	0.000578	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.55e-06	0.000567	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	3.5e-06	0.000559	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	3.33e-06	0.000531	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	3.3e-06	0.000527	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	3.25e-06	0.000519	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	3.17e-06	0.000506	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	3.06e-06	0.000489	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	3.06e-06	0.000488	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	3.05e-06	0.000487	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	3.03e-06	0.000484	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	2.86e-06	0.000456	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	2.81e-06	0.000449	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.8e-06	0.000447	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	2.74e-06	0.000438	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.68e-06	0.000428	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	2.64e-06	0.000422	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.62e-06	0.000418	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	2.59e-06	0.000414	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	2.59e-06	0.000413	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	2.58e-06	0.000412	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	2.56e-06	0.000409	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.47e-06	0.000394	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.45e-06	0.00039	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	2.43e-06	0.000388	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	2.41e-06	0.000385	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	2.19e-06	0.00035	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	2.16e-06	0.000345	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	2.12e-06	0.000338	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	2.11e-06	0.000336	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.09e-06	0.000334	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	2.06e-06	0.000329	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	2e-06	0.000319	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	1.99e-06	0.000317	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	1.97e-06	0.000314	CbGpPWpGaD
Sertraline—MAOB—Metabolism—AKT1—peripheral nervous system neoplasm	1.96e-06	0.000313	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.95e-06	0.000311	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	1.93e-06	0.000308	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	1.69e-06	0.00027	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.68e-06	0.000268	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.65e-06	0.000263	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.61e-06	0.000258	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	1.59e-06	0.000254	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	1.3e-06	0.000207	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	1.27e-06	0.000203	CbGpPWpGaD
Sertraline—MAOA—Metabolism—AKT1—peripheral nervous system neoplasm	1.23e-06	0.000196	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	7.71e-07	0.000123	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	5.83e-07	9.3e-05	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	5.69e-07	9.08e-05	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	5.36e-07	8.55e-05	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	5.31e-07	8.48e-05	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	4.54e-07	7.25e-05	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	3.5e-07	5.59e-05	CbGpPWpGaD
